Molecular Devices Announces Webcast of Presentation at CIBC World Markets Conference

Apr 26, 2001, 01:00 ET from Molecular Devices Corporation

    SUNNYVALE, Calif., April 26 /PRNewswire/ --
 Molecular Devices Corporation (Nasdaq:   MDCC) announced today that its
 presentation at the CIBC World Markets First Annual Bio-Technology Investor
 Conference, held in New York, will be webcast live on Wednesday, May 2, at
 8:40 a.m. (Eastern Time). Senior Management of Molecular Devices will be
 presenting an overview of the company.
     Interested investors can access the live webcast at
 http://www.cibcwm.com/eq/conference/biotech .
     A replay of the presentation will be archived for three months on the CIBC
 conference website.
     Molecular Devices Corporation is a leading developer of high-performance,
 bioanalytical measurement systems that accelerate and improve drug discovery
 and other life sciences research. Molecular Devices' systems enable
 pharmaceutical and biotechnology companies to leverage advances in genomics
 and combinatorial chemistry by facilitating the high throughput and cost
 effective identification and evaluation of drug candidates. Molecular Devices'
 instrument systems are based on its advanced core technologies which integrate
 its expertise in engineering, molecular and cell biology and chemistry and are
 fundamental tools for drug discovery and life sciences research.
 
                      MAKE YOUR OPINION COUNT - Click Here
                http://tbutton.prnewswire.com/prn/11690X15238578
 
 

SOURCE Molecular Devices Corporation
    SUNNYVALE, Calif., April 26 /PRNewswire/ --
 Molecular Devices Corporation (Nasdaq:   MDCC) announced today that its
 presentation at the CIBC World Markets First Annual Bio-Technology Investor
 Conference, held in New York, will be webcast live on Wednesday, May 2, at
 8:40 a.m. (Eastern Time). Senior Management of Molecular Devices will be
 presenting an overview of the company.
     Interested investors can access the live webcast at
 http://www.cibcwm.com/eq/conference/biotech .
     A replay of the presentation will be archived for three months on the CIBC
 conference website.
     Molecular Devices Corporation is a leading developer of high-performance,
 bioanalytical measurement systems that accelerate and improve drug discovery
 and other life sciences research. Molecular Devices' systems enable
 pharmaceutical and biotechnology companies to leverage advances in genomics
 and combinatorial chemistry by facilitating the high throughput and cost
 effective identification and evaluation of drug candidates. Molecular Devices'
 instrument systems are based on its advanced core technologies which integrate
 its expertise in engineering, molecular and cell biology and chemistry and are
 fundamental tools for drug discovery and life sciences research.
 
                      MAKE YOUR OPINION COUNT - Click Here
                http://tbutton.prnewswire.com/prn/11690X15238578
 
 SOURCE  Molecular Devices Corporation